FDA Drug recall D-0181-2023
Advil (ibuprofen) Tablets, 200 mg, packaged as a) 360-count bottles (UPC 3 0573 0154 60 4), and b) 200-count bottles (UPC 3 0573 0154 21 5)…
- FDA Drug
- Class I
- terminated
- Published 2023-02-01
On 2023-02-01 the FDA classified a Class I recall of Advil (ibuprofen) Tablets, 200 mg, packaged as a) 360-count bottles (UPC 3 0573 0154 60 4), and b) 200-count bottles (UPC 3 0573 0154 21 5)… by Glaxosmithkline Consumer Healthcare Holdings, citing labeling: Illegible Label; the adhesive migrated onto a portion of the label, causing it to tear when peeled back.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0181-2023 |
| Classification | Class I |
| Status | terminated |
| Initiated | 2022-12-06 |
| Published | 2023-02-01 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Glaxosmithkline Consumer Healthcare Holdings |
| Distribution | US |
Product
Advil (ibuprofen) Tablets, 200 mg, packaged as a) 360-count bottles (UPC 3 0573 0154 60 4), and b) 200-count bottles (UPC 3 0573 0154 21 5), Pfizer, Madison, NJ 07940
Reason
Labeling: Illegible Label; the adhesive migrated onto a portion of the label, causing it to tear when peeled back
Identifiers
| upc | 305730154604 |
|---|---|
| upc | 305730154215 |
| code_info | a) Lots EJ2218, EJ2219, EJ2220, Exp 09/2023; b) Lot 953D, Exp 05/2025 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0181-2023%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.